Warning: main(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /home/lmbric5/public_html/cake/libs/debugger.php on line 558

Strict Standards: Non-static method Debugger::getInstance() should not be called statically, assuming $this from incompatible context in /home/lmbric5/public_html/cake/libs/debugger.php on line 558

Warning: mysql_connect() [function.mysql-connect]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /home/lmbric5/public_html/cake/libs/model/datasources/dbo/dbo_mysql.php on line 117

Deprecated: mysql_connect() [function.mysql-connect]: The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/lmbric5/public_html/cake/libs/model/datasources/dbo/dbo_mysql.php on line 117
LMBRI and Lipopharma Lead Collaboration to Promote new Cancer drug and diagnostics development

LMBRI and Lipopharma Lead Collaboration to Promote new Cancer drug and diagnostics development

BOSTON, USA/Palma de Mallorca SPAIN - June 15, 2010

LMBRI LLC and Lipopharma Therapeutics SL today announced collaboration aimed at transforming cancer drug development and improving patient outcomes. Lipopharma developed new assessment approaches, methods and technologies for developing cancer therapeutics and diagnostics using their proprietary design of structure-based molecules that regulate the structure and functions of the membrane lipids, instead targeting cellular proteins, called “Membrane Lipid-Therapy (MLT)”.
Under terms of the agreement, Lipopharma is appointing LMBRI to commercialize its world-wide rights of its platform technology and products for licensing and marketing.
Companies jointly will provide lipid based drug development technology and enhancement in product pipeline   to bring more effective and less toxic cancer therapeutics
Vicenç Tur, CEO of Lipopharma Therapeutics, SL said that “we are very excited to collaborate with LMBRI with the goal to provide to the US market with this new technology and approach the problem of drug development from a new perspective.” He also declares that “we have chosen LMBRI as our partner in the US because of their profound knowledge of the US market and their well-regarded reputation as consultants for the biopharma industry globally.
“We have entered this collaboration with the view to bring Lipopharma’s unique technology to pharmaceutical and healthcare industries in the US. This collaboration has allowed us to provide our pharmaceutical  clients an access to Lipopharma’s innovative technology and products.” says Svetlana Dey, Managing Director of LMBRI, LLC.

About LMBRI
Lana Management & Business Research International (LMBRI) is a global management consulting and contract management firm on business strategy, product management and marketing. We partner with clients to identify their highest-value opportunities, high-risk programs, address their most critical challenges, and transform them into high-performance and profitable business entities. www.lmbri.com

About Lipopharma
Lipopharma is an innovative Biotech company based in Palma de Mallorca (Spain) that specializes in the rational design and early clinical development of pharmaceutical/nutraceutical products aimed at the prevention and treatment of human pathologies. The design of molecules is based on structure-function principles according to the unique MLT know-how developed by Lipopharma’s scientific team. www.lipopharma.com

Contacts

LMBRI LLC
neil.dey@lmbri.com
Tel: 877-562-7418

Lipopharma Therapeutics SL
v.tur@lipopharma.com
Tel: ( 34) 653 900 858